Analytical Data
-
Gene name
FLJ20449
- Application
-
Alternative Names
bHLHe81; FLJ20449; FLJ57222; SOHLH2; Solh2; SOLH2_HUMAN; SPATA28; Spermatogenesis and oogenesis specific basic helix loop helix 2; Spermatogenesis associated 28; Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2; TEB1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NX45
-
Expression Region
1-425aa
-
AA Sequence
MASSIICQEH CQISGQAKID ILLVGDVTVG YLADTVQKLF ANIAEVTITI SDTKEAAALL DDCIFNMVLL KVPSSLSAEE LEAIKLIRFG KKKNTHSLFV FIIPENFKGC ISGHGMDIAL TEPLTMEKMS NVVKYWTTCP SNTVKTENAT GPEELGLPLQ RSYSEHLGYF PTDLFACSES LRNGNGLELN ASLSEFEKNK KISLLHSSKE KLRRERIKYC CEQLRTLLPY VKGRKNDAAS VLEATVDYVK YIREKISPAV MAQITEALQS NMRFCKKQQT PIELSLPGTV MAQRENSVMS TYSPERGLQF LTNTCWNGCS TPDAESSLDE AVRVPSSSAS ENAIGDPYKT HISSAALSLN SLHTVRYYSK VTPSYDATAV TNQNISIHLP SAMPPVSKLL PRHCTSGLGQ TCTTHPNCLQ QFWAY
-
Molecular Weight
46.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of the recombinant protein FLJ20449 stems from its potential implications in various biological processes and disease mechanisms. FLJ20449, initially identified through genomic sequencing projects, has been suggested to play a role in cellular functions due to its unique structural properties and expression patterns. Research has indicated that this protein may be involved in regulatory pathways and could have implications in conditions such as cancer, metabolic disorders, and immune responses. Given the rise of personalized medicine and targeted therapies, understanding the functional dynamics of FLJ20449 could unveil novel therapeutic targets or biomarkers for disease diagnosis and treatment. Furthermore, recombinant technology allows for the production of this protein in controlled laboratory settings, facilitating detailed studies on its biochemical properties, interactions with other biomolecules, and its physiological roles. Investigating FLJ20449 also contributes to the broader understanding of human proteomics, offering insights into the complexity of protein interactions and functions within the cellular environment. This makes it a significant candidate for further biological research and potential clinical applications, highlighting the importance of continued exploration into its mechanisms and effects within various physiological contexts.
